Michael Son is currently the Vice President of Global Regulatory Affairs for Ocular Health at Alcon, a position they began in 2023. They previously served as Vice President of Regulatory Affairs at Equillium, Inc. from 2021 to 2023. With extensive experience in the regulatory field, Michael held various roles at Allergan, including Director of Global Regulatory Affairs from 2012 to 2020, and worked at Samsung Bioepis and Watson Pharmaceuticals as well. Michael earned a Ph.D. in Molecular Pharmacology & Toxicology and an M.S. in Clinical & Regulatory Sciences from the University of Southern California.
This person is not in the org chart
This person is not in any teams
This person is not in any offices